New Risk • Jan 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Israeli stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Market cap is less than US$100m (₪99.2m market cap, or US$31.4m). お知らせ • Jan 13
C-Lab Ltd, Annual General Meeting, Feb 16, 2026 C-Lab Ltd, Annual General Meeting, Feb 16, 2026. Location: co. offices, Israel Buy Or Sell Opportunity • Dec 17
Now 21% undervalued Over the last 90 days, the stock has risen 5.5% to ₪9.55. The fair value is estimated to be ₪12.01, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.9% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Sep 16
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 7.7% to ₪9.38. The fair value is estimated to be ₪12.04, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.9% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Mar 27
Full year 2024 earnings released: EPS: ₪0.34 (vs ₪2.42 in FY 2023) Full year 2024 results: EPS: ₪0.34 (down from ₪2.42 in FY 2023). Revenue: ₪87.7m (down 33% from FY 2023). Net income: ₪2.87m (down 86% from FY 2023). Profit margin: 3.3% (down from 16% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. New Risk • Mar 09
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (₪107.5m market cap, or US$29.7m). お知らせ • Dec 06
C-Lab Ltd, Annual General Meeting, Jan 09, 2025 C-Lab Ltd, Annual General Meeting, Jan 09, 2025. Location: co. offices, Israel Board Change • Aug 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Independent Director Yanir Farber was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • May 03
Investor sentiment deteriorates as stock falls 33% After last week's 33% share price decline to ₪10.60, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 23x in the Tech industry in Asia. Total loss to shareholders of 38% over the past three years. Reported Earnings • Mar 21
Full year 2023 earnings released: EPS: ₪2.42 (vs ₪0.82 in FY 2022) Full year 2023 results: EPS: ₪2.42 (up from ₪0.82 in FY 2022). Revenue: ₪130.0m (up 9.0% from FY 2022). Net income: ₪20.5m (up 194% from FY 2022). Profit margin: 16% (up from 5.9% in FY 2022). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. New Risk • Mar 19
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Israeli stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). Earnings have declined by 1.4% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (₪145.7m market cap, or US$39.8m). Valuation Update With 7 Day Price Move • Mar 19
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₪17.18, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 24x in the Tech industry in Asia. Total returns to shareholders of 10% over the past three years. New Risk • Mar 14
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.4% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (₪119.4m market cap, or US$32.9m). Valuation Update With 7 Day Price Move • Jan 01
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₪13.57, the stock trades at a trailing P/E ratio of 10.9x. Average trailing P/E is 23x in the Tech industry in Asia. Total loss to shareholders of 19% over the past year. New Risk • Aug 30
New major risk - Revenue and earnings growth Earnings have declined by 1.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.4% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₪129.5m market cap, or US$34.1m). Valuation Update With 7 Day Price Move • Mar 29
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₪16.81, the stock trades at a trailing P/E ratio of 20.4x. Average trailing P/E is 15x in the Tech industry in Asia. Negligible returns to shareholders over past year. Reported Earnings • Mar 25
Full year 2022 earnings released: EPS: ₪0.82 (vs ₪0.14 in FY 2021) Full year 2022 results: EPS: ₪0.82 (up from ₪0.14 in FY 2021). Revenue: ₪119.3m (up 43% from FY 2021). Net income: ₪6.98m (up 493% from FY 2021). Profit margin: 5.9% (up from 1.4% in FY 2021). The increase in margin was driven by higher revenue. お知らせ • Oct 03
CompuLab Ltd. (TASE:CLAB) announces an Equity Buyback for ILS 1 million worth of its shares. CompuLab Ltd. (TASE:CLAB) announces a share repurchase program. Under the program, the company will repurchase up to ILS 1 million worth of its shares. The repurchases will be funded from company's cash balance. The plan will be valid till October 2, 2023. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Shai Tsabari was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Mar 30
Full year 2021 earnings released: EPS: ₪0.14 (vs ₪1.35 in FY 2020) Full year 2021 results: EPS: ₪0.14 (down from ₪1.35 in FY 2020). Revenue: ₪83.3m (down 21% from FY 2020). Net income: ₪1.18m (down 90% from FY 2020). Profit margin: 1.4% (down from 11% in FY 2020). The decrease in margin was driven by lower revenue. Valuation Update With 7 Day Price Move • May 24
Investor sentiment improved over the past week After last week's 18% share price gain to ₪20.06, the stock trades at a trailing P/E ratio of 14.9x. Average trailing P/E is 20x in the Tech industry in Asia. Reported Earnings • Mar 24
Full year 2020 earnings released: EPS ₪1.35 (vs ₪0.64 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: ₪105.3m (down 1.8% from FY 2019). Net income: ₪11.5m (up 110% from FY 2019). Profit margin: 11% (up from 5.1% in FY 2019). The increase in margin was driven by lower expenses.